Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions.

NCT07149220 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Oral Leukoplakia
Oral Dysplasia

Interventions

DRUG: Mucoadhesive fenretinide-releasing system (FMS)

Sponsor

Ohio State University

Collaborators

[object Object]